Autism rates hold steady across birth cohorts, pointing to detection rather than epidemic

Overview

Updated 1 hour ago

A study published this week in JAMA Pediatrics examined birth cohorts in Denmark and found that the seven-year cumulative incidence of autism spectrum disorder (ASD) remained stable across 12 consecutive birth cohorts. The finding directly challenges the idea that autism is becoming more common, and instead points to improved detection as the main driver of rising reported rates.

The study is part of a broader shift in autism epidemiology. Multiple population-wide registries in Denmark, Sweden, and Finland now show the same pattern: more children are being diagnosed at younger ages, the male-to-female gap is narrowing, and cumulative incidence keeps climbing into adulthood for older cohorts, meaning many people were simply missed for decades.

If detection explains the rise, the public health challenge shifts from understanding a mystery epidemic to ensuring equitable, timely diagnosis for the people who were historically missed — especially girls and adults.

Why it matters

If detection drives the autism rise, the public health question shifts from what's causing an epidemic to why girls and adults are still diagnosed years late.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

Has anyone ever considered is levels of Autism is an evolutionary advantage for the human species

Yes—researchers have considered it: autism-linked genes may have persisted because traits like systemizing and intense focus were useful in ancestral environments, but today's rising diagnosis rates are a detection artifact, not an evolutionary shift.

Why it matters: The answer shapes whether autism is seen as a disorder to treat or a cognitive difference to support.

Autism is 60–90% heritable, and a Danish registry study found genetic factors consistently outweighed environmental ones in explaining autistic traits over time.
The 'balanced selection' hypothesis holds that autism-associated traits—systematic thinking, pattern recognition, solitary focus—could have been adaptive in ancestral niches, so the underlying variants were kept even when they also cause disability.
A related theory, 'assortative mating,' suggests people with strong systemizing skills are more likely to carry autism-linked genes and to pair up, concentrating those genes in the population.
Danish registry data show 60% of the reported increase in ASD among children born 1980–1991 is explained by changes in diagnostic criteria and inclusion of outpatient contacts—not by a change in human biology.
The recent Danish cohort studies in the story found cumulative incidence stable across consecutive birth cohorts, reinforcing that better detection, not evolution, drives the rising numbers.

Sources

Room for disagreement

Proponents of the 'different cognitive style' view argue autism-linked traits were positively selected and carry real strengths; critics, including many autistic self-advocates, counter that autism is a disability and that evolutionary 'advantages' are speculative and risk downplaying the need for support.
The balancing-selection hypothesis is hard to test directly—no study has shown that autism-associated alleles actually increased reproductive fitness in ancestral humans.

AI-generated with web search — may be wrong. Check the linked sources.

Key Indicators

2.80%

Max cumulative ASD incidence by age 16 (2000-2001 birth cohort)

Peak cumulative incidence in Denmark; the curves show no plateau for more recent cohorts.

Consecutive birth cohorts with stable 7-year cumulative incidence

Stability across cohorts suggests detection, not increased occurrence, drives reported rises.

6.5% / 3.9%

Cumulative ASD incidence by age 18 (males/females, Denmark 2000-2024)

Substantial rise over two decades, most pronounced among girls, narrowing the historical sex gap.

1.2

Male-to-female cumulative incidence ratio by age 20 (Sweden, 2022)

Ratio dropped from roughly 4:1 historically; projected to reach parity by 2024.

31,961

ASD diagnoses among 2,055,928 Danish births (1980-2012)

Registry-based cohort study with follow-up through 2016.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

People Involved

Diana Scheinerman

Lead author of JAMA Pediatrics study

Active researcher

Organizations Involved

JAMA Pediatrics

Peer-reviewed medical journal

Published the stable-incidence study

The American Medical Association's journal for pediatric research.

Centers for Disease Control and Prevention (CDC)

Federal public health agency

Maintains U.S. ASD prevalence surveillance

U.S. agency that tracks autism via the Autism and Developmental Disabilities Monitoring (ADDM) Network.

Timeline

1980 September 2026

9 events Latest: Today

Tap a bar to jump to that date

September 2026
r/science community shares the stable-incidence findings
Today Discussion

The study reaches top of day on r/science, drawing attention to detection-related factors in ASD increases.
Today
Danish 2000-2024 incidence trends published in European Child & Adolescent Psychiatry
Today Research

Incidence risen substantially, most pronounced among girls; cumulative incidence 6.5% male, 3.9% female by age 18.
Today
JAMA Pediatrics study shows stable cumulative incidence across 12 cohorts
Research

7-year cumulative ASD incidence remained stable, pointing to detection rather than increased occurrence.
Yesterday
January 2025
Swedish study shows male-to-female ratio narrowing to 1.2
Research

Among 2.7 million births 1985-2020, ratio projected to reach parity by 2024 at age 20.
January 15th, 2025
May 2022
ADDM Network reports progress in early identification
Surveillance

Substantially more children identified early than in the past, especially those without intellectual disability.
May 1st, 2022
January 2019
Danish cumulative incidence study published in JAMA
Research

Registry study of 1980-2012 births finds no plateau in curves, suggesting incidence has not stabilized.
January 15th, 2019
April 2018
CDC reports 1.68% autism prevalence among US 8-year-olds
Surveillance

Rate 14% higher than 2012 and 2010 figures, raising questions about rising occurrence.
April 26th, 2018
2000
Danish national registries begin tracking ASD diagnoses
Surveillance

Psychiatric Central Research and National Patient Registers record ASD diagnoses by medical specialists.
2000
1980
Denmark begins systematic birth cohort tracking
Surveillance

All live births in Denmark identified in the Central Person Register for follow-up through 2016.
1980

Scenarios

Detection hypothesis solidifies as consensus; screening expands for underdiagnosed groups

Likely Resolves by End of 2027

Discussed by: CIDRAP, JAMA Pediatrics authors, Danish registry researchers

The stable incidence across cohorts gains traction, and public health agencies shift focus to late-diagnosed adults, girls, and minority groups. Screening programs expand beyond early childhood, and the male-to-female ratio continues to approach parity. More research funding moves to diagnostic tools for adults and females.

Incidence continues to rise with no plateau; debate over causes deepens

Possible Resolves by Q2 2028

Discussed by: Skeptical epidemiologists, environmental health researchers

More recent cohorts show higher cumulative incidence at younger ages, suggesting the Danish curve may continue climbing beyond 2.8%. Researchers point to prenatal exposures, parental age, and other factors. The detection hypothesis faces criticism for not fully explaining the trend.

Data quality questions emerge; differential diagnosis uncertainty dominates

Unlikely Resolves by End of 2028

Discussed by: Methodologists, psychiatric diagnosticians

Researchers challenge whether registry diagnoses are consistent across cohorts, noting changes in ICD coding and clinical practice. The stable-incidence result is questioned for not accounting for diagnostic substitution from intellectual disability or other conditions.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

1990-2000

Ritalin and ADHD diagnostic expansion (1990s)

ADHD diagnoses rose sharply in the 1990s following expanded diagnostic criteria, school-based screening, and public awareness campaigns. Similar to autism today, reported incidence climbed far beyond what demographic changes could explain.

Then

Prescription stimulant use multiplied; treatment access expanded.

Now

Researchers now largely attribute the rise to broadening diagnostic thresholds and better recognition, not an underlying biological epidemic. The pattern offers a direct template for autism epidemiology.

Why this matters now

ADHD's trajectory shows how diagnostic expansion and awareness can produce rising incidence numbers that later stabilize when the system reaches saturation. Autism's Danish data may reflect the same process.

1998-2010

The MMR vaccine-autism controversy (1998-2010)

Andrew Wakefield published a now-retracted Lancet paper linking the MMR vaccine to autism. The claim triggered a massive public health scare and a wave of anti-vaccine activism, even as large population studies found no association.

Then

Vaccination rates dropped in some communities; multiple outbreaks of measles followed.

Now

The Lancet retracted the paper in 2010; Wakefield lost his medical license. The episode remains a cautionary tale about how poorly designed studies can distort public perception.

Why this matters now

The vaccine controversy showed how attribution of an autism 'epidemic' to a single cause can distort public health priorities. Today's detection-vs-epidemic debate is more nuanced, but the stakes are similar: getting the mechanism right matters for policy.

May 2013

DSM-5 diagnostic criteria revision (2013)

The American Psychiatric Association consolidated several autism subdiagnoses into one autism spectrum disorder category. The change collapsed diagnostic boundaries, allowing more people to qualify for an ASD diagnosis.

Then

Some people with prior diagnoses lost or gained coverage depending on the new criteria; diagnostic rates shifted.

Now

The broadened spectrum contributed to higher reported prevalence and made cross-era comparisons of incidence rates difficult.

Why this matters now

Diagnostic substitution and criteria expansion are two factors researchers cite for the reported autism rise. The DSM-5 change is a concrete example of how classification shapes epidemiological numbers.